The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils
- PMID: 1378071
The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils
Abstract
The gene product of the steel locus of the mouse represents a growth factor for murine mast cells and a ligand for the c-kit proto-oncogene receptor, a member of the tyrosine kinase receptor class of oncogenes (for review, see O. N. Witte. 1990. Cell 63:5). We have studied the effect of the human recombinant c-kit receptor ligand stem cell factor (rhSCF) on the release of inflammatory mediators from human skin mast cells and peripheral blood basophils and compared its activity to that of rhIL-3, rhSCF (1 ng/ml to 1 microgram/ml) activated the release of histamine and PGD2 from mast cells isolated from human skin. Analysis by digital video microscopy indicated that purified human skin mast cells (84 +/- 5% pure) responded to rhSCF (0.1 to 1 microgram/ml) challenge with a rapid, sustained rise in intracellular Ca2+ levels that was accompanied by secretion of histamine. A brief preincubation (10 min) of mast cells with rhSCF (0.1 pg/ml to 1 ng/ml) significantly enhanced (100 +/- 35%) the release of histamine induced by anti-IgE (3 micrograms/ml), but was much less effective on IgE-mediated release of PGD2. In contrast, a short term incubation with rhSCF did not potentiate the secretion of histamine activated by substance P (5 microM). A 24-h incubation of mast cells with rhSCF did not affect the release of mediators induced by anti-IgE (3 micrograms/ml), probably due to receptor desensitization, rhSCF (1 ng/ml to 3 micrograms/ml) neither caused release of histamine or leukotriene C4 (LTC4) release from leukocytes of 14 donors, nor induced a rise in intracellular Ca2+ levels in purified (greater than 70%) basophils. Brief preincubation (10 min) of leukocytes with rhSCF (1 ng/ml to 3 micrograms/ml) caused an enhancement (69 +/- 11%) of anti-IgE-induced release of histamine that was significant at concentrations as low as 3 ng/ml (p less than 0.05), whereas it appeared less effective in potentiating IgE-mediated LTC4 release. In contrast, a prolonged incubation (24 h) with rhSCF (0.1 pg/ml to 100 ng/ml) did not enhance the release of histamine or LTC4 induced by anti-IgE (0.1 microgram/ml), whereas rhIL-3 (3 ng/ml) significantly potentiated the release of both mediators.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.J Pharmacol Exp Ther. 1993 Dec;267(3):1375-85. J Pharmacol Exp Ther. 1993. PMID: 7505332
-
Protein L. A bacterial Ig-binding protein that activates human basophils and mast cells.J Immunol. 1990 Nov 1;145(9):3054-61. J Immunol. 1990. PMID: 1698870
-
Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell.J Pharmacol Exp Ther. 1988 Oct;247(1):209-17. J Pharmacol Exp Ther. 1988. PMID: 2459368
-
Mechanisms of activation of human mast cells and basophils by general anesthetic drugs.Ann Fr Anesth Reanim. 1993;12(2):116-25. doi: 10.1016/s0750-7658(05)81020-2. Ann Fr Anesth Reanim. 1993. PMID: 7690200 Review.
-
Omalizumab may not inhibit mast cell and basophil activation in vitro.J Eur Acad Dermatol Venereol. 2015 Sep;29(9):1832-6. doi: 10.1111/jdv.12693. Epub 2014 Sep 26. J Eur Acad Dermatol Venereol. 2015. PMID: 25257818 Review.
Cited by
-
Mast Cells and Basophils in IgE-Independent Anaphylaxis.Int J Mol Sci. 2023 Aug 15;24(16):12802. doi: 10.3390/ijms241612802. Int J Mol Sci. 2023. PMID: 37628983 Free PMC article. Review.
-
Interferon-gamma promotes the survival and Fc epsilon RI-mediated histamine release in cultured human mast cells.Immunology. 1996 Dec;89(4):547-52. doi: 10.1046/j.1365-2567.1996.d01-768.x. Immunology. 1996. PMID: 9014819 Free PMC article.
-
Macrophage inflammatory protein-1alpha as a costimulatory signal for mast cell-mediated immediate hypersensitivity reactions.J Clin Invest. 2005 Feb;115(2):434-42. doi: 10.1172/JCI18452. J Clin Invest. 2005. PMID: 15650768 Free PMC article.
-
β-Cell Receptor Tyrosine Kinases in Controlling Insulin Secretion and Exocytotic Machinery: c-Kit and Insulin Receptor.Endocrinology. 2018 Nov 1;159(11):3813-3821. doi: 10.1210/en.2018-00716. Endocrinology. 2018. PMID: 30239687 Free PMC article. Review.
-
Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes.Arch Dermatol Res. 1994;287(1):78-84. doi: 10.1007/BF00370723. Arch Dermatol Res. 1994. PMID: 7537033 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Miscellaneous